<?xml version="1.0" encoding="UTF-8"?>
<p>Stem cell transplantation is an important treatment for hematologic malignancies offering a potential cure and a treatment option for advanced disease. However, chronic graft-
 <italic>versus</italic>-host disease (GvHD) is a major cause of morbidity and mortality after a transplant.
 <sup>
  <xref rid="b1-1040189" ref-type="bibr">1</xref>
 </sup> Chronic GvHD is a multisystem disease, however its current grading system categorizes disease compositely as mild, moderate or severe.
 <sup>
  <xref rid="b2-1040189" ref-type="bibr">2</xref>â€“
  <xref rid="b4-1040189" ref-type="bibr">4</xref>
 </sup> The current grading system may overlook clinically relevant patterns of chronic GvHD organ scores. For example, a patient with severe skin sclerosis and a patient with highly elevated liver enzymes are both classified as having severe chronic GvHD, despite starkly different clinical manifestations of the disease.
 <sup>
  <xref rid="b3-1040189" ref-type="bibr">3</xref>
 </sup>
</p>
